Detectable IL-8 and IL-10 in bronchoalveolar lavage fluid from preterm infants ventilated for respiratory distress syndrome

Pediatric Research

Volumn 52, Issue 6, 2002, Pages 973-978

  Beresford, Michael W ^a   Shaw, Nigel J ^a  

^a LIVERPOOL WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL LUNG SURFACTANT; INTERLEUKIN 10; INTERLEUKIN 8; PORACTANT; SURFACTANT; LUNG SURFACTANT;

ARTICLE; ARTIFICIAL VENTILATION; CHRONIC LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLAMMATION; LUNG LAVAGE; MAJOR CLINICAL STUDY; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PROTEIN DETERMINATION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY DISTRESS SYNDROME; CHRONIC DISEASE; IMMUNOLOGY; LUNG DISEASE; METABOLISM; NEONATAL RESPIRATORY DISTRESS SYNDROME; PROGNOSIS; TIME;

BRONCHOALVEOLAR LAVAGE FLUID; CHRONIC DISEASE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKIN-10; INTERLEUKIN-8; LUNG DISEASES; PROGNOSIS; PULMONARY SURFACTANTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN; TIME FACTORS;

EID: 85047681755     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200212000-00025     Document Type: Article

References (28)

1. Groneck P, Speer CP 1995 Inflammatory mediators and bronchopulmonary dysplasia. Arch Dis Child Fetal Neonatal Ed 73:F1-F3
2. Kotecha S 1996 Cytokines in chronic lung disease of prematurity. Eur J Pediatr 155(suppl 2):S14-S17
3. Jones CA, Cayabyab RG, Kwong KY, Stotts C, Wong B, Hamdan H, Minoo P, Delemos RA 1996 Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: A possible developmental basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 39:966-975
4. Kwong KY, Jones CA, Cayabyab R, Lecart C, Stotts CL, Randhawa I, Ramanathan R, Khuu N, Minoo P, Delemos RA 1998 Differential regulation of IL-8 by IL-1 beta and TNFalpha in hyaline membrane disease. J Clin Immunol 18:71-80
5. Tullus K, Noack GW, Bunnan LG, Nilsson R, Wretlind B, Brauner A 1996 Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 155:112-116
6. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR 1993 Interleukin-10. Annu Rev Immunol 11:165-190
7. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE 1991 Interleukin-10 inhibits cytokine synthesis by human monocytes. An autoregulatory of IL-10 produced by monocytes. J Exp Med 174:1209-1220
8. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A 1991 IL-10 inhibits cytokine production by activated macrophages. J Immunol 147:3815-3822
9. McCohn J, Stenson BJ, Biermasz N, McIntosh N 2000 Measurement of interleukin 10 in bronchoalveolar lavage from preterm ventilated infants. Arch Dis Child Fetal Neonatal Ed 82:F156-F159
10. Jónsson B, Li H-Y, Noack G, Brauner A, Tullus K 2000 Downregulatory cytokines in tracheobronchial aspirate fluid from infants with chronic lung disease of prematurity. Acta Paediatr 89:1375-1380
11. Ainsworth SB, Beresford MW, Milligan DWA, Shaw NJ, Matthews JNS, Fenton AC, Ward Platt MP 2000 Pumactant and poractant alfa for treatment of respiratory distress syndrome in neonates born at 25-29 weeks' gestation: A randomised trial. Lancet 355:1387-1392
12. Bland JM, Altman DG 1986 Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1:307-310
13. Marshall-Clarke S, Reen D, Tasker L, Hassan J 2000 Neonatal immunity: How well has it grown up. Immunol Today 21:35-41
14. Dargaville PA, South M, McDougall PN 1999 Comparison of two methods of diagnostic lung lavage in ventilated infants with lung disease. Am J Respir Crit Care Med 160:771-777
15. ERS Task Force 2000 Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. Eur Respir J 15:217-231
16. Jónsson B, Tullus K, Brauner A, Lu Y, Noack G 1997 Early increase of TNF alpha and IL-6 in tracheobronchial aspirate fluid indicator of subsequent chronic lung disease in preterm infants. Arch Dis Child Fetal Neonatal Ed 77:F198-F201
17. Little S, Dean T, Bevin S, Hall M, Ashton M, Church M, Warner J, Shute J 1995 Role of elevated plasma soluble ICAM-1 and bronchial lavage fluid IL-8 levels as markers of chronic lung disease in premature infants. Thorax 50:1073-1079
18. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ 1995 Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 72:F90-F96
19. Arnon S, Grigg J, Silverman M 1993 Pulmonary inflammatory cells in ventilated preterm infants: Effect of surfactant treatment. Arch Dis Child 69:44-48
20. Murch SH, Costeloe K, Klein NJ, MacDonald TT 1996 Early production of macrophage inflammatory protein-la occurs in respiratory distress syndrome and is associated with poor outcome. Pediatr Res 40:490-497
21. Creuwels LAJM, van Golde LMG, Haagsman HP 1997 The pulmonary surfactant system: Biochemical and clinical aspects. Lung 175:1-39
22. Takahashi A, Nemoto T, Fujiwara T 1994 Biophysical properties of protein-free, totally synthetic pulmonary surfactants, ALEC and Exosurf, in comparison with surfactant TA. Acta Paediatr Jpn 36:613-618
23. Corcoran JD, Berggren P, Sun B, Halliday HL, Robertson B, Curstedt T 1994 Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits. Arch Dis Child Fetal Neonatal Ed 71:F165-F169
24. Kotecha S 1999 Bronchoalveolar lavage of newborn newbom infants. Pediatr Pulmonol Suppl 18:122-124
25. Dargaville PA, South M, Vervaart P, McDougall PN 1999 Validity of markers of dilution in small volume lung lavage. Am J Respir Crit Care Med 160:778-784
26. Haslam PL, Baughman RP 1999 Report of ERS Task Force: Guidelines for management of acellular components and standardization of BAL. Eur Respir J 14:245-248
27. Kotecha S, Wangoo A, Silverman M, Shaw RJ 1996 Increase in the concentration of transforming growth factor beta-1 in bronchoalveolar lavage fluid before development of chronic lung disease of prematurity. J Pediatr 128:464-469
28. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ 1996 Increase in interleukin (IL)-1β and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 40:250-256